PROGRAM OVERVIEW:
The introduction of anti-VEGF agents for the treatment of age-related macular degeneration (AMD), diabetic retinopathy (DR), and retinal vein occlusion (RVO), transformed the management of these conditions. While the clinical benefits of these compounds are well documented their use brings up other issues for ophthalmologists, namely, cost. Thus, payers have become more involved in managing the use of these agents, potentially interfering with clinical decision making. This live event brings together thought leaders in the retina field to discuss the challenges they face in obtaining access to anti-VEGF medications for their patients, and how they overcome those challenges.
LEARNING OBJECTIVES:
Upon completion of this activity, the participant should be able to:
- Identify and Implement algorithms, decision-making tools, and patient communication approaches that can be used to determine the most appropriate treatment for the patient.
- Identify opportunities to advocate against prior authorizations and step policies and appeal them.
- Discuss the potential impact of the Drug Quality and Security Act and opportunities to advocate for continued access to compounded ophthalmologic drugs.
- Describe the impact of the Medicare Access and CHIP Reauthorization Act (MACRA) on ophthalmology and its potential impact on the prescribing of anti-VEGF agents.
ACCREDITATION STATEMENT
Evolve Medical Education LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT
Evolve Medical Education LLC designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
GRANTOR STATEMENT
Supported through an educational grant from Regeneron Pharmaceuticals, Inc.
Evolve Medical Education LLC fully complies with the legal requirements of the ADA and the rules and requirements thereof. If any participant in this educational activity is in need of accommodations please contact Evolve Medical Education at 215.439.2080 by July 1, 2018 for assistance.
Provided by 
This program is not affiliated with ASRS.
|
